SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-20-001434
Filing Date
2020-10-15
Accepted
2020-10-15 11:02:45
Documents
15
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aphria6k.htm 6-K 11845
2 Q1 FINANCIAL STATEMENTS ex991.htm EX-99.1 841506
3 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 451331
4 CEO AND CFO CERTIFICATES ex993.htm EX-99.3 18339
5 GRAPHIC logo.jpg GRAPHIC 37382
6 GRAPHIC logo_footer.jpg GRAPHIC 6516
7 GRAPHIC mda_aphria.jpg GRAPHIC 14826
8 GRAPHIC mda_bingo.jpg GRAPHIC 24797
9 GRAPHIC mda_blue.jpg GRAPHIC 3598
10 GRAPHIC mda_brokencoast.jpg GRAPHIC 25406
11 GRAPHIC mda_cover.jpg GRAPHIC 277428
12 GRAPHIC mda_goodsupply.jpg GRAPHIC 10545
13 GRAPHIC mda_pof.jpg GRAPHIC 16626
14 GRAPHIC mda_riff.jpg GRAPHIC 5650
15 GRAPHIC mda_solei.jpg GRAPHIC 22174
  Complete submission text file 0001279569-20-001434.txt   1938322
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 201240722
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences